New dialysis approach could reduce bleeding risks in kidney patients
NCT ID NCT07579663
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new, personalized way of giving a blood thinner (citrate) during kidney dialysis to the standard method. It involves 142 adults with acute kidney injury or advanced chronic kidney disease who also have liver failure or poor blood flow. The goal is to see if the new approach keeps calcium levels more stable, reducing the need for adjustments and improving safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AKI - ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple vein pressure reading may warn of kidney failure days earlier
- Smarter magnesium testing could shield Children's hearts and kidneys after surgery
- New drug aims to shield kidneys during heart surgery
- Timing of kidney dialysis in ICU: could earlier start save days?
- Kidney check: do current AKI tests really work in the ICU?
- Can a heart drug shield kidneys during bypass surgery?